INTERPHASE CYTOGENETICS REVEALS A HIGH-INCIDENCE OF ANEUPLOIDY AND INTRA-TUMOR HETEROGENEITY IN BREAST-CANCER

被引:42
作者
FIEGL, M
TUENI, C
SCHENK, T
JAKESZ, R
GNANT, M
REINER, A
RUDAS, M
PIRCDANOEWINATA, H
MAROSI, C
HUBER, H
DRACH, J
机构
[1] UNIV VIENNA,DEPT SURG 2,VIENNA,AUSTRIA
[2] UNIV VIENNA,DEPT CLIN PATHOL,VIENNA,AUSTRIA
关键词
INTERPHASE CYTOGENETICS; BREAST CANCER; ANEUPLOIDY; METASTASIS;
D O I
10.1038/bjc.1995.276
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The occurrence of aberrations involving chromosomes 11 and 17 in malignant tissues of breast cancer patients has not yet been studied systematically. Using fluorescence in situ hybridisation (FISH) with centromere-specific probes, we determined chromosome 11 and 17 status in interphase nuclei from primary and/or metastatic breast cancer cells. In all cancerous specimens obtained from 30 patients, FISH identified cells with clonal chromosomal abnormalities, with aneuploidy rates ranging from 6% to 92% (median 59%). There was a gain of centromeric signals for chromosome 11, most likely corresponding to hyperploidy; aberrations of chromosome 17 in specimens from 26 patients (87%) were hyperploid as well; however, four cases (13%) showed loss of chromosome 17 centromeres. All specimens contained heterogeneous aneuploid cell populations with excessive gain of signals in some cases. The pattern of aneuploidy did not appear to correlate with tumour grade/stage and was comparable in primary rumours and corresponding metastatic axillary lymph nodes, indicative of genetic instability early in tumour development. Screening with a panel of FISH probes may lead to enhanced sensitivity and specificity in detecting malignant cells, as demonstrated in this study with effusions which could not be conclusively interpreted as being malignant by cytological criteria.
引用
收藏
页码:51 / 55
页数:5
相关论文
共 38 条
[1]   THE APPLICABILITY OF A KERATIN 7 MONOCLONAL-ANTIBODY IN ROUTINELY PAPANICOLAOU-STAINED CYTOLOGIC SPECIMENS FOR THE DIFFERENTIAL-DIAGNOSIS OF CARCINOMAS [J].
BAARS, JH ;
DERUIJTER, JLM ;
SMEDTS, F ;
VANNIEKERK, CC ;
POELS, LG ;
SELDENRIJK, CA ;
RAMAEKERS, FCS .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 101 (03) :257-261
[2]   TRISOMY-7 - A POTENTIAL CYTOGENETIC MARKER OF HUMAN PROSTATE-CANCER PROGRESSION [J].
BANDYK, MG ;
ZHAO, L ;
TRONCOSO, P ;
PISTERS, LL ;
PALMER, JL ;
VONESCHENBACH, AC ;
CHUNG, LWK ;
LIANG, JC .
GENES CHROMOSOMES & CANCER, 1994, 9 (01) :19-27
[3]   COMPARATIVE-ASSESSMENT OF DNA ANALYSIS IN EFFUSIONS BY IMAGE-ANALYSIS AND FLOW-CYTOMETRY [J].
BANKS, ER ;
JENNINGS, CD ;
JACOBS, S ;
DAVEY, DD .
DIAGNOSTIC CYTOPATHOLOGY, 1994, 10 (01) :62-67
[4]  
BEERMAN H, 1991, CYTOMETRY, V12, P147, DOI 10.1002/cyto.990120208
[5]  
BENTZ M, 1993, LEUKEMIA, V7, P752
[6]  
BRUGGER W, 1994, BLOOD, V83, P636
[7]  
CAJULIS RS, 1994, ANAL QUANT CYTOL, V16, P1
[8]   DNA IMAGE CYTOMETRY ON MACHINE-SELECTED BREAST-CANCER CELLS AND A COMPARISON BETWEEN FLOW-CYTOMETRY AND SCANNING CYTOPHOTOMETRY [J].
CORNELISSE, CJ ;
VANDRIELKULKER, AM .
CYTOMETRY, 1985, 6 (05) :471-477
[9]   DETECTION OF CHROMOSOME-ABERRATIONS IN THE HUMAN INTERPHASE NUCLEUS BY VISUALIZATION OF SPECIFIC TARGET DNAS WITH RADIOACTIVE AND NONRADIOACTIVE INSITU HYBRIDIZATION TECHNIQUES - DIAGNOSIS OF TRISOMY-18 WITH PROBE L1.84 [J].
CREMER, T ;
LANDEGENT, J ;
BRUCKNER, A ;
SCHOLL, HP ;
SCHARDIN, M ;
HAGER, HD ;
DEVILEE, P ;
PEARSON, P ;
VANDERPLOEG, M .
HUMAN GENETICS, 1986, 74 (04) :346-352
[10]   VALUE OF DNA ANALYSIS IN ADDITION TO CYTOLOGICAL TESTING IN THE DIAGNOSIS OF MALIGNANT PLEURAL EFFUSIONS [J].
DECASTRO, FR ;
MOLERO, T ;
ACOSTA, O ;
JULIASERDA, G ;
CAMINERO, J ;
CABRERA, P ;
CARRILLO, T .
THORAX, 1994, 49 (07) :692-694